Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study-Reference-Cited by-同舟云学术

Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study

Published:2016-12-23 Issue:5 Volume:89 Page:849-856
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Kang Seong Hee¹,Kang Keunhee²,Jong Eun Yeon²,Lee Young Sun²,Kim Tae Suk²,Yoo Yang Jae²,Suh Sang Jun²,Yoon Eileen L.³,Jung Young Kul²,Kim Ji Hoon²,Seo Yeon Seok²,Yim Hyung Joon²,Byun Kwan Soo²

Affiliation:

1. Department of Internal Medicine; Wonju Severance Christian Hospital; Yonsei University, Wonju College of Medicine; Wonju

2. Division of Gastroenterology and Hepatology; Department of Internal Medicine; Korea University College of Medicine; Republic of Korea

3. Department of Internal Medicine, Sanggye Paik Hospital; Inje University College of Medicine; Republic of Korea

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.24715/fullpdf

Reference43 articles.

1. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: A long term cohort study;Brunetto;J Hepatol,2002

2. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response;Chan;Clin Gastroenterol Hepatol,2007

3. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B;Chang;N Engl J Med,2006

4. From hepatitis to hepatoma: Lessons from type B viral hepatitis;Chen;Science,1993

5. Distribution of hepatitis B virus genotypes in Korea;Cho;Korean J Hepatol,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial;Journal of Hepatology;2024-07

2. Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis;Frontiers in Public Health;2022-11-03

3. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2022-04-01

4. Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients;Hepatology Research;2022-02-21

5. Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis;Gut;2021-09-07